Ignite Creation Date:
2024-05-06 @ 8:48 AM
Last Modification Date:
2024-10-26 @ 12:05 PM
Study NCT ID:
NCT02829840
Status:
WITHDRAWN
Last Update Posted:
2017-06-02
First Post:
2016-07-05
Brief Title:
Dose-Escalation Study of Ponatinib a FLT3 Inhibitor With and Without Combination of 5-Azacytidine in Patients With FLT3-Mutated Acute Myeloid Leukemia AML
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09
Start Date Type:
None
Primary Completion Date:
2021-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2016-07-05
First Submit QC Date:
July 7 2016
Study First Post Date:
2016-07-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-01
Last Update Post Date:
2017-06-02
Last Update Post Date Type:
ACTUAL